Evaluation of the efficacy, safety and injection interval of intravitreal injection of ranibizumab for retinal vein occlusion
Latest Information Update: 19 Mar 2019
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinal vein occlusion
- Focus Therapeutic Use
- 16 Mar 2019 Status changed from active, no longer recruiting to completed.
- 21 Oct 2013 New trial record